Clinical Trial Update: Spartina® (Tirzepatide) Effectiveness and Safety Evaluation

View source ↗

Summary

Spartina (tirzepatide) is undergoing a clinical trial to evaluate its effectiveness and safety in obesity/overweight, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Spartina (tirzepatide)

Snippet

Sponsor: Cinnagen | Conditions: Obesity & Overweight | Status: RECRUITING